Contrast Media Market Size, Growth, Share & Trends Analysis
Contrast Media Market By Type (lodinated Contrast Media), Form (Liquid, Powder), Modality (X-ray, MRI, Ultrasound), Route of Administration (Oral, Rectal), Indication (Cancer, Neurological, GI, Musculoskeletal Disorders) & Region - Global Forecast to 2031
OVERVIEW
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
The Contrast Media market, valued at USD 7.65 billion in 2025, stood at USD 8.20 billion in 2026 and is projected to advance at a resilient CAGR of 7.9% from 2026 to 2031, culminating in a forecasted valuation of USD 12.08 billion by the end of the period. Factors driving this growth include the increase in people with chronic conditions, like cardiovascular disease, cancer and neurological disorders, and, also, increase in the number of people getting diagnostic imaging tests on a global basis. In addition, continuous advancements in technology relating to imaging modalities (CT scans, MRIs, and Interventional Radiology) have created a high demand for advanced safety and efficacy of new contrast solutions/products. The trend toward using minimally invasive methods for performing diagnostic procedures and using image-guided methods to perform interventional procedures is another driver of market growth. Emerging economies are also developing their healthcare infrastructure and are increasing the number of elderly people in their population. As well as these developing areas/countries, researchers are developing new low-osmolar/iso-osmolar types of contrast that are significantly safer than current marketed contrast materials, creating additional growth opportunities for the global contrast media market.
KEY TAKEAWAYS
-
BY REGIONThe Asia Pacific region is projected to witness the highest CAGR of 9.5% in the contrast media market.
-
BY PRODUCT TYPEBy type, the iodinated contrast media segment is estimated to account for the highest market share of 55% in 2026.
-
BY MODALITYBy modality, the CT segment is expected to register the highest CAGR of 8.2%.
-
BY INDICATIONBy indication, the cardiovascular disease segment is expected to dominate the market with 48.0% revenue share in 2026.
-
BY ROUTE OF ADMINISTRATIONBY route of administration, The intravascular segment is estimated to account for the largest market share of 77.0% in 2026.
-
BY FORMBy form, the liquid segment is projected to grow at the fastest rate of 7.7% from 2026 to 2031.
-
BY APPLICATIONThe interventional radiology is estimated to account for the largest market share of 40.0% in 2026.
-
BY END USERBy end user, the diagnostic imaging centers segment is projected to register the highest CAGR of 9.0% during the forecast period.
-
COMPETITIVE LANDSCAPE- KEY PLAYERSGE HealthCare (US), Bracco Imaging S.p.A. (Italy), Bayer AG (Germany), and Guerbet (France) are identified as some of the star players in the contrast media market, given their strong global market presence, extensive contrast agent portfolios, advanced R&D capabilities, and well-established distribution networks across developed and emerging regions.
-
COMPETITIVE LANDSCAPE- OTHER PLAYERSCompanies such as Jodas Expoim Pvt. Ltd. (India), Ultratrust (India), Imax Diagnostic Imaging Limited (India), and J.B. Chemicals & Pharmaceuticals Ltd. (India) have distinguished themselves among startups and SMEs in the contrast media market by establishing strong footholds in cost-competitive generic contrast agents, regional distribution networks, and hospital-focused supply models, underscoring their potential as emerging market leaders in developing and price-sensitive markets.
The contrast media market is driven by the is the rising demand for accurate and rapid diagnosis of chronic diseases such as cancer, cardiovascular, and neurological disorders. Market expansion has also benefited from the rise in diagnostic imaging procedures and the preference for minimally invasive, image-guided interventions. Advances in technology such as low, osmolar and iso, osmolar contrast agents, microbubble contrast agents for ultrasound imaging, and improved delivery systems contribute to patient safety and provide more accurate imaging.
TRENDS & DISRUPTIONS IMPACTING CUSTOMERS' CUSTOMERS
Transformative trends and various disruptions are reshaping the contrast media market. Industry players are witnessing an evolution of low, osmolar and iso, osmolar contrast agents to more sophisticated levels, along with the introduction of gadolinium-based macrocyclic formulations and microbubble contrast agents for ultrasound, which are aimed at enhancing safety and increasing diagnostic accuracy. A growing number of hospitals and diagnostic imaging centers are adopting artificial intelligence (AI), driven imaging analysis, automated injector systems, and dose optimization technology as means of improving the efficiency of their workflows and reducing the occurrence of adverse events.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
MARKET DYNAMICS
Level
-
Rising Prevalence of Chronic Diseases
-
Advancements in Contrast Agent Formulations
Level
-
Risk of Adverse Reactions
-
High Cost of Imaging Procedures
Level
-
Growth of Interventional Radiology and Image-Guided Procedures
-
Development of Microbubble and Ultrasound Contrast Agents
Level
-
Workforce Shortages in Radiology
-
Supply Chain Vulnerabilities
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Driver: Rising Prevalence of Chronic Diseases
The increase in chronic diseases is a major driver of growth for the contrast media industry. The WHO states that almost 75% of the number of deaths worldwide are from non-communicable diseases, resulting in around 43 million people dying every year. Cardiovascular Diseases affect 620 million individuals globally, and diabetes affects over 800 million people worldwide. Because diagnostic imaging techniques like contrast-enhanced CT, MRI, and angiography depend on contrast media for better visualization of vascular systems, tissues, and pathological alterations, this increased global disease load immediately translates into higher volumes of these procedures. One of the main factors driving the growth in contrast media utilization across diagnostic imaging and interventional radiology applications is the rising frequency of chronic diseases.
Restraint: Risk of Adverse Reactions
The risk of adverse reactions from the use of contrast media is a major factor limiting the market growth. Iodinated and gadolinium, based contrast agents are capable of causing various side effects, ranging from mild symptoms like nausea and itching to more severe conditions, e. g., contrast, induced nephropathy (CIN), allergic reactions, and even anaphylaxis in patients who are predisposed. Due to the concerns about the potential harm to health from these, doctors tend to be more careful in giving contrast, enhanced imaging, especially to patients who already have kidney problems or allergies, thus limiting the total usage. Besides, stricter regulatory controls and safety checks also have an impact on hospital guidelines and could lead to a decrease in the number of procedures carried out in high, risk groups.
Opportunity: Development of Microbubble and Ultrasound Contrast Agents
The rise in the use of contrast-enhanced ultrasound is opening up considerable opportunities for the contrast media market. Microbubble-based contrast agents offer real-time visualization of blood vessels with a very high level of safety since they are not nephrotoxic and, therefore, are ideal for patients with renal impairment. The use of these agents is going up in liver lesion characterization, cardiac imaging, and vascular diagnostics, which in turn is leading to a decrease in the use of CT and MRI for those indications. Besides that, ultrasound systems are cheaper and more easily available, especially in developing countries, which is an added factor for the CEUS growth. The ongoing research in making microbubbles more stable and capable of targeted imaging will likely broaden the clinical applications and be a factor for the future market growth.
Challenge: Supply Chain Vulnerabilities
The market for contrast agents is the high level of dependence on iodine for producing iodinated contrast agents as well as for some advanced formulations and rare earth materials. The number of countries producing iodine around the world is limited, so disruptions within the supply chain could easily be caused by Geopolitical tensions,Trade limitations and Disruptions in production. At the same time, any shortages or price fluctuations in these key raw materials could immediately impact the production capacity and pricing of the manufactured products. Another form of uncertainty regarding the supply of raw materials arises through restrictions on mining and environmental regulations. The presence of these uncertainties surrounding the supply of raw materials increases the level of risk associated with manufacturing operations. As a result, temporary shortages of products within medical facilities may result from decreased access to supply chains that are affected by external factors (such as geopolitical instability).
CONTRAST MEDIA MARKET SIZE, GROWTH, SHARE & TRENDS ANALYSIS: COMMERCIAL USE CASES ACROSS INDUSTRIES
| COMPANY | USE CASE DESCRIPTION | BENEFITS |
|---|---|---|
 |
It provides a comprehensive portfolio of iodinated and gadolinium-based agents for CT, MRI, and X-ray imaging. | Enhances diagnostic clarity across diverse patient populations while utilizing sustainable, recyclable packaging systems. |
 |
It offers specialized contrast agents and syringeless injectors (like Max 3) for MRI and ultrasound (CEUS) applications. | Improves lesion visualization with high-relaxivity agents that require lower gadolinium doses, prioritizing patient safety. |
 |
It develops high-quality contrast media for MRI (Gadavist) and the first FDA-approved agent for Contrast-Enhanced Mammography. | Facilitates precise detection of CNS lesions and breast pathologies through advanced imaging and personalized dosing software. |
 |
It designs innovative macrocyclic agents (Elucirem) and digital injection management solutions like Contrast&Care. | Enables high-quality imaging at half the conventional gadolinium dose, reducing potential long-term tissue deposition. |
 |
Aplio i-series Ultrasound Systems – Incorporates Micro-Vascular Imaging (SMI) and contrast-enhanced ultrasound (CEUS) for vascular imaging in peripheral and abdominal applications | Enables visualization of low-velocity blood flow in micro vessels, enhances detection of vascular lesions and plaque morphology, supports real-time evaluation without ionizing radiation, and improves diagnostic accuracy in early vascular disease detection |
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET ECOSYSTEM
The contrast media market comprises various stakeholders, including manufacturers of contrast media, suppliers of raw materials, distributors, healthcare facilities such as hospitals and diagnostic imaging centers, universities and research sites, regulatory authorities, and together they create a complex network of exchange and value creation. Manufacturers innovate by developing better iodinated and gadolinium-based contrast agents, new formulation technologies, and safer contrasts. Suppliers provide the active pharmaceutical ingredient (API) or excipient required for manufacturing contrast agents for the four primary types of imaging modalities: CT, MRI, ultrasound, and interventional procedures. Distributors or group purchasing organizations (GPOs) facilitate the availability of contrast media products in different regions and across the global healthcare systems. Regulatory authorities such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) set high, quality standards, issue guidelines for the efficacy, and continue pharmacovigilance after the product is approved for use. Hospitals, diagnostic imaging centers, and research institutions play a vital role in clinical adoption and evaluation of contrast agents across CT, MRI, ultrasound, and interventional procedures. Key companies operating in this ecosystem include Bayer AG (Germany), Bracco Imaging S.p.A. (Italy), and Guerbet (France), GE HealthCare (US)a, mong others, forming an integrated and highly regulated global value chain.
Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.
MARKET SEGMENTS
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
Contrast Media Market, By Type
Iodinated contrast media are anticipated to hold the highest CAGR as a result of a growing number of CT scans and interventional procedures globally. The clinical preference is continually being driven by its high image clarity and strong compatibility with advanced CT imaging systems. The rising usage in cardiovascular, oncology, and trauma diagnostics is also helping to increase the demand. Continuous product innovations oriented towards the development of low, osmolar, and iso, osmolar formulations are enhancing patient safety and acceptance. Moreover, the increasing availability of emergency and outpatient imaging services is speeding up the use of iodinated contrast agents.
Contrast Media Market, By Form
The liquid form is the rapidly expanding segment in the contrast media market as it can be easily administered by intravenous and oral routes during imaging procedures. It gives quicker absorption and even distribution in the body which helps in obtaining clearer and more accurate diagnostic results. The growing use of automated injectors and infusion systems is also a factor in the increased use of liquid contrast agents. Besides this, liquid formulations allow for better dosing flexibility and they are compatible with the latest CT and MRI systems. The increasing number of outpatient and emergency imaging procedures is another factor driving demand for liquid contrast media.
Contrast Media Market, By Modality
CT is the fastest growing modality in the contrast media market. This is because it has been most widely adopted for the rapid and accurate diagnosis of cardiovascular, neurological, and oncological conditions. The rise in the prevalence of chronic diseases and trauma cases has resulted in the increasing demand for CT, based imaging procedures. The technological innovations such as multi, slice CT scanners and AI, based image reconstruction have made possible high quality images and increased diagnostic accuracy. CT scans have the advantage of shorter examination times and allow more patients to be seen than other modalities. Moreover, the increasing utilization of CT in emergency care and preventive screening programs is giving an extra boost to the demand for contrast-enhanced CT imaging.
Contrast Media Market, By Indication
Cardiovascular disease has the fastest growing market share of all the contrast media indications globally due to the increasing incidence of cardiovascular diseases resulting from an aging population, sedentary lifestyle, increasing rates of obesity and diabetes and as people will have access to more advanced diagnostic modalities such as CT angiograms, Coronary angiograms, and Cardiac MRIs which are all requiring the use of contrast. There are also dynamic markets (emerging countries) where access to interventional cardiology procedures and better healthcare infrastructure will support market growth. Finally, there will continue to be advances in technology related to Cardiac Imaging systems and hence improved accuracy and significant increase in new procedure volumes.
Contrast Media Market, By Route of Administration
The oral route of administration is the fastest, growing modality in the contrast media market mainly because it is non-invasive and provides better patient comfort than injectable methods. For gastrointestinal imaging and abdominal CT scans, it is broadly used as it lessens the work of intravenous access. The increasing focus on outpatient and preventive diagnostics has led to a higher demand for contrast agents that are easier to administer. A decreased risk of allergic reactions and increased formulation stability have also helped to broaden the use of these agents. Increasingly, patients are becoming aware of and prefer safer, more convenient diagnostic procedures which is another factor driving market growth.
Contrast Media Market, By Application
By application, contrast media market is categorized into radiology, interventional radiology, interventional cardiology. Contrast?????? media market share is led by radiology, which is a major contributor to diagnostic imaging and the largest number of contrast-enhanced procedures carried out worldwide. In general, CT, MRI, and angiography are the main methods where contrast agents are used to make the images clearer and to be more accurate in diagnosing a wider range of diseases that include cardiovascular, neurological, and oncological ones. As a result, the prevalence of these chronic diseases, the need for early and accurate diagnosis, and the upgrading of hospital and diagnostic center infrastructures for advanced imaging procedures have become some of the reasons for the rising use of contrast media in radiology. Besides that, the use of contrast agents as a standard step in imaging protocols and their regular application in radiological procedures contribute significantly to radiology being the largest driver of the market ??????demand.
REGION
Asia Pacific to be fastest-growing region in global vascular imaging market during forecast period
The Asia Pacific is the fastest growing region in the contrast media market.The main reasons behind this are the rapid development of healthcare facilities and an upsurge in the number of diagnostic imaging centers. The demand for advanced imaging techniques is being driven by the rising prevalence of chronic and lifestyle diseases, such as cancer and cardiovascular disorders. Also, improved awareness about early diagnosis and better healthcare access along with increased government support are contributing to the market expansion. In addition to that, medical tourism and the existence of low, cost manufacturing hubs are also facilitating a rapid adoption of the contrast media in the region..
CONTRAST MEDIA MARKET SIZE, GROWTH, SHARE & TRENDS ANALYSIS: COMPANY EVALUATION MATRIX
Bracco Imaging S.p.A., Bayer AG lead the contrast media market with with high product footprints and robust business strategies. They possess extensive portfolios and lead in innovation. Emerging leaders, such asTaejoon Pharm Co., Ltd., Yangtze River Pharmaceutical (YZJ) Group, strong product innovation but may currently lack the expansive business reach or long-term strategic depth of the Stars. Pervasive players, including J.B. Chemicals & Pharmaceuticals Limited, Sanochemia Pharmazeutika GmbH, have strong business strategies and global presence but tend to offer more specialized, limited, or less diversified product lines. Participants are niche players with narrow offerings and limited strategic development, contributing minimally to competitive market dynamics.
Source: Secondary Research, Interviews with Experts, MarketsandMarkets Analysis
KEY MARKET PLAYERS
- GE HealthCare (US)
- Bracco Imaging S.p.A. (Italy)
- Bayer AG (Germany)
- Guerbet (US)
- Lantheus Medical Imaging (US)
- Unijules Life Sciences Ltd. (India)
- J.B. Chemicals & Pharmaceuticals Limited (India)
- Sanochemia Pharmazeutika GmbH (Germany)
- Taejoon Pharm Co., Ltd. (South Korea)
- Jodas Expoim (India)
MARKET SCOPE
| REPORT METRIC | DETAILS |
|---|---|
| Market Size in 2025 (Value) | USD 7.65 Billion |
| Market Forecast in 2031 (Value) | USD 12.08 Billion |
| Growth Rate | CAGR of 7.9% from 2026-2031 |
| Years Considered | 2023-2030 |
| Base Year | 2025 |
| Forecast Period | 2026-2031 |
| Units Considered | Value (USD Billion) |
| Report Coverage | Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
| Segments Covered |
|
| Regions Covered | North America, Asia Pacific, Europe, Latin America, Middle East & Africa |
| Related Segment & Geographic Reports |
Asia-Pacific Contrast Media Market Europe Contrast Media Market United States Contrast Media Market |
WHAT IS IN IT FOR YOU: CONTRAST MEDIA MARKET SIZE, GROWTH, SHARE & TRENDS ANALYSIS REPORT CONTENT GUIDE
DELIVERED CUSTOMIZATIONS
We have successfully delivered the following deep-dive customizations:
| CLIENT REQUEST | CUSTOMIZATION DELIVERED | VALUE ADDS |
|---|---|---|
| Contrast Media Manufacturer |
|
|
| Healthcare Provider / Hospital Network |
|
|
| Investor / Private Equity Firm |
|
|
RECENT DEVELOPMENTS
- Febuary 2026 : India’s CDSCO approved Bayer’s Ultravist (Iopromide Injection) as the first iodinated contrast agent for use in Contrast-Enhanced Mammography (CEM). This landmark decision provides a faster, more accessible diagnostic alternative to breast MRI for visualizing breast lesions and improving cancer detection across India.
- Febuary 2025 : GE HealthCare is investing $138 million to construct a new 32,000-square-foot manufacturing facility in Cork, Ireland, to meet a projected doubling in global demand for iodine-based contrast media over the next decade.
- April 2023 : GE HealthCare expanded its contrast media portfolio by introducing Pixoscan (gadobutrol), a macrocyclic, non-ionic magnetic resonance imaging (MRI) gadolinium-based contrast agent (GBCA). Pixoscan underwent regulatory review via a decentralized procedure (DCP), securing marketing authorization in Austria.
- October 2023 : The European Commission granted Guerbet marketing authorization (MA) for Elucirem (Gadopiclenol). This followed a positive opinion from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) for its use as an MRI contrast agent.
Table of Contents
Exclusive indicates content/data unique to MarketsandMarkets and not available with any competitors.
Methodology
The study involved four main activities to estimate the current size of the contrast media market. Extensive secondary research was conducted to gather information on the market, peer, and parent markets. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up methods were used to estimate the overall market size. Subsequently, market segmentation and data triangulation were employed to estimate the market sizes of various segments and subsegments.
Secondary Research
The secondary research process involves the widespread use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, company house documents, investor presentations, and SEC filings of companies. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial contrast media market study. It was also used to obtain important information about the key players and market classification & segmentation according to industry trends to the bottom-most level, and key developments related to market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.
Primary Research
In the primary research process, various supply and demand sources were interviewed to obtain qualitative and quantitative information for this report. The primary sources on the supply side include industry experts such as CEOs, vice presidents, marketing and sales directors, technology & innovation directors, and other key executives from leading companies and organizations in the contrast media market. The primary sources from the demand side include hospitals and multispecialty healthcare systems, and diagnostic imaging and radiology centers. Primary research was conducted to validate the market segmentation, identify key players, and gather insights on key industry trends & key market dynamics.
*Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
Note: Companies are classified into tiers based on their total revenue. As of 2025, Tier 1 = >USD 1,000 million, Tier 2 = USD 500–1,000 million, and Tier 3 = USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
In this report, the contrast media market’s size was determined using the revenue share analysis of leading players. For this purpose, key market players were identified, and their market revenues were determined using insights gathered during the primary and secondary research phases. Secondary research included analyzing the annual and financial reports of the top market players. In contrast, primary research included extensive interviews with key opinion leaders, including CEOs, directors, and senior marketing executives.
Segmental revenues were calculated based on the revenue mapping of major solution/service providers to calculate the global market value. This process involved the following steps:
- Generating a list of major global players operating in the contrast media market.
- Mapping annual revenues generated by major global players from the type segment (or nearest reported business unit/product category)
- Revenue mapping of major players to cover a major share of the global market, as of 2025
- Extrapolating the global value of the contrast media market industry
Contrast Media Market : Top-Down and Bottom-Up Approach
Data Triangulation
After arriving at the overall market size through the market size estimation process explained above, the global contrast media market was segmented and subsegmented. Data triangulation and market breakdown procedures were employed to complete the overall market engineering process and obtain exact statistics for all segments and subsegments. The data was triangulated by studying various factors and trends from both the demand and supply sides. Additionally, the contrast media market was validated using top-down and bottom-up approaches.
Market Definition
Contrast media are administered to patients to enhance the visibility of internal organs, tissues, and blood vessels during diagnostic techniques such as X-ray, CT, MRI, and ultrasound. The market includes iodinated, gadolinium-based, microbubble, and barium-based contrast media used across hospitals, diagnostic centers, clinics, and ambulatory surgery centers.
Key Stakeholders
- Manufacturers and Suppliers
- Healthcare Providers
- Regulatory Authorities
- Distributors and Wholesalers
- Logistics and Cold-Chain Providers
- Healthcare IT and PACS Providers
- Training and Professional Associations
- Venture capitalists and investors
- Radiology centers
- Medical imaging and nuclear medicine consultants
Report Objectives
- To define, describe, and forecast the size of the contrast media market based on type, form, route of administration, modality, indication, application, end user, and region
- To provide detailed information regarding the major factors influencing the growth potential of the global contrast media market (drivers, restraints, opportunities, challenges, and trends)
- To analyze the micro markets with respect to individual growth trends, prospects, and contributions to the global contrast media market.
- To analyze key growth opportunities in the global contrast media market for key stakeholders and provide details of the competitive landscape for market leaders
- To forecast the size of market segments and/or subsegments with respect to five major regions, namely, North America (US and Canada), Europe (Germany, France, UK, Italy, Spain, and Rest of Europe), Asia Pacific (Japan, China, India, Australia, South Korea, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America), and the Middle East & Africa
- To profile the key players in the contrast media market and comprehensively analyze their market shares and core competencies
- To track and analyze the competitive developments undertaken in the global contrast media market, such as product launches, agreements, expansions, and mergers & acquisitions
Available customizations:
Based on the given market data, MarketsandMarkets offers customizations tailored to the company’s specific needs. The following customization options are available for the present global contrast media market report:
Product Analysis
- Product matrix, which gives a detailed comparison of the product portfolios of the top five companies
Company Information
- Detailed analysis and profiling of additional market players (up to five)
Geographic Analysis
- Further breakdown of the Rest of Europe contrast media market into Russia, Belgium, the Netherlands, Switzerland, Austria, Finland, Sweden, Poland, and Portugal, among others
- Further breakdown of the Rest of Asia Pacific contrast media market into Singapore, Taiwan, New Zealand, the Philippines, Malaysia, and other APAC countries
- Further breakdown of the Latin American contrast media market into Colombia, Chile, Argentina, and Peru, among others
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This ReportPersonalize This Research
- Triangulate with your Own Data
- Get Data as per your Format and Definition
- Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
- Any level of Personalization
Let Us Help You
- What are the Known and Unknown Adjacencies Impacting the Contrast Media Market
- What will your New Revenue Sources be?
- Who will be your Top Customer; what will make them switch?
- Defend your Market Share or Win Competitors
- Get a Scorecard for Target Partners
Custom Market Research Services
We Will Customise The Research For You, In Case The Report Listed Above Does Not Meet With Your Requirements
Get 10% Free CustomisationTESTIMONIALS
JAYANT RAJPUROHIT
Director of Market Insights, Data and Analytics
SFI Health,
Leading Pharmaceutical Companywww.sfihealth.com/
We at SFI Health approached MarketsandMarkets for an Opportunity Assessment on "Incidence and Prevalence of Focus Indications" as we wanted to know the most attractive HCPs like Physician, Functional MD, Naturopath and Pharmacist. The project was critical for us to ensure our focus on the right target which would enable sustainable growth and profitability for SFI Health. The business insights provided exceeded our expectations and we were extremely impressed. The team at MarketsandMarkets is highly professional and detail oriented and very well understood our business needs. MarketsandMarkets offers a unique combination of expertise and dedicated engagement model. We identified 2 new products to be launched in coming months, based on the research findings provided by MarketsandMarkets. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.
BEATRIZ DE LA CALLE
Head of Commercial Analytics
Qualicaps,
Leading Pharmaceutical Companywww.qualicaps.com/
We partnered with MarketsandMarkets for an assessment study on hard empty capsules. The team was extremely professional in understanding our business requirements and we received timely responses to all our queries. The market intelligence and the recommendations has met our business requirements. We were extremely impressed to see the final study results; it really exceeded our expectations. The market intelligence offered by MarketsandMarkets, and clarity on next steps will help us achieve our business objective for the Year 2021. We are happy with the services and would strongly recommend MarketsandMarkets to my peers in the industry.
Bob Williams,
Senior Director Business Development & Innovation
Bracco Diagnostics Inc.,
Italian Multinational in life sciences sector and a World Leader in imaging diagnosticsimaging.bracco.com/us-en
We were pleased with targeted insights that MarketsandMarkets identified from a custom study on the 'Radiation Dose Management Solutions Market'. Your team identified and characterized the market participants as well as underlying trends accurately. This study was useful to Bracco in formulating business strategies for our dose monitoring product lines and we thank MarketsandMarkets for the job well done.
Cody Coonradt,
Market Development and Strategy Manager
3M Health Information Systems,
Leader in Health care Coding, Payment & Analytics Solutions.www.3m.com/3M/en_US/health-information-systems-us
The value for our organization comes from three things: depth of research, specificity of segments and being easy to work with. As important as the first two are, the third can't be underestimated. MarketsandMarkets, maybe more than any other research vendor, wants to know what is top of mind for our team and what big questions we are grappling to answer.
Their customer first approach and high value engagement model, have given us great analysis and excellent value for money
Growth opportunities and latent adjacency in Contrast Media Market
Still Researching the
Contrast Media Ecosystem?
See the competitors, opportunities, and growth signals shaping it - instantly.
Generate 15+ consulting-grade strategic insights tailored to your growth question.
MarketsandMarkets
Jun, 2022
1) The contrast media/contrast agents market is segmented into barium-based contrast media, iodinated contrast media, gadolinium-based contrast media, and microbubble contrast media. In 2020, the iodinated contrast media segment accounted for the largest share of XX of the contrast media/contrast agents market. The large share of this segment can be attributed to the increasing demand for early disease diagnosis and image-guided procedures (resulting in a rising volume of CT and Xray procedures). 2) The barium-based contrast media market is expected to register low growth due to its limited use in various procedures and the associated adverse effects of these agents on organs. 3) Microbubble contrast agents are generally regarded as safe to use and are gaining popularity because of the large number of ongoing academic research activities exploring various attributes of microbubbles in off-label indications (in diagnosis as well as drug delivery). The growing number of approvals for microbubble contrast agents in major markets is also driving the growth of this market segment..
Pisal
May, 2022
We need the list of vendors in Contrast Media Market. Please help .
Elan
May, 2022
Can you please help us with study related to contrast media injectors market ?.
M.Y.Zahid
Nov, 2019
We intend to import and sale to our customer non ionic contract media, X-Ray, Angiography, CT, MRI users, Please send us price list. M.Y.Zahid, [email protected].
Orion
Jun, 2026
After reviewing the Contrast Media Market report, I see steady demand linked to rising imaging procedures, which makes me cautious about capacity planning for suppliers in this space..
Lyra
Jun, 2026
I find the segmentation of the Contrast Media Market particularly useful for understanding how iodinated and gadolinium-based agents are evolving alongside advances in CT and MRI workflows..
Nova
Jun, 2026
From an investment standpoint, the Contrast Media Market shows resilient growth drivers, but I would closely monitor regulatory pressure and safety concerns that could impact long-term margins..